Shopping Cart 0
Cart Subtotal
AED 0

RespireRx Pharmaceuticals Inc (RSPI) - Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

RespireRx Pharmaceuticals Inc (RSPI)-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

RespireRx Pharmaceuticals Inc (RespireRx), formerly Cortex Pharmaceuticals, Inc. involved in the discovery, development and commercialization of innovative products for the treatment of various respiratory disorders (RD) and CNS problems. RespireRx focuses on attention deficit hyperactivity disorder, obstructive sleep apnea (OSA), spinal cord injury and other neurological disorders. Its lead product, Dronabinol, an oral capsule drug product completed Phase II trials for the treatment of OSA. The company's other pipeline products include CX1739 in Chronic CSA, CX717 in spinal cord injury and opioid; CX1942 in drug induced RD. RespireRx is headquartered in Glen Rock, New Jersey, the US.

RespireRx Pharmaceuticals Inc Key Recent Developments

Jan 03,2019: RespireRx Pharmaceuticals names James Sapirstein as executive vice board chairman

Dec 10,2018: Respirerx Pharmaceuticals executives presenting at the international cannabinoid derived pharmaceuticals summit

Jul 25,2018: RespireRx Pharmaceuticals Announces Publication of Ampakine Data

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

RespireRx Pharmaceuticals Inc-Key Facts

RespireRx Pharmaceuticals Inc-Key Employees

RespireRx Pharmaceuticals Inc-Key Employee Biographies

RespireRx Pharmaceuticals Inc-Major Products and Services

RespireRx Pharmaceuticals Inc-History

RespireRx Pharmaceuticals Inc-Company Statement

RespireRx Pharmaceuticals Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

RespireRx Pharmaceuticals Inc-Business Description

RespireRx Pharmaceuticals Inc-SWOT Analysis

SWOT Analysis-Overview

RespireRx Pharmaceuticals Inc-Strengths

RespireRx Pharmaceuticals Inc-Weaknesses

RespireRx Pharmaceuticals Inc-Opportunities

RespireRx Pharmaceuticals Inc-Threats

RespireRx Pharmaceuticals Inc-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

RespireRx Pharmaceuticals Inc, Recent Deals Summary

Section 4-Company's Recent Developments

Jan 03, 2019: RespireRx Pharmaceuticals names James Sapirstein as executive vice board chairman

Dec 10, 2018: Respirerx Pharmaceuticals executives presenting at the international cannabinoid derived pharmaceuticals summit

Jul 25, 2018: RespireRx Pharmaceuticals Announces Publication of Ampakine Data

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

RespireRx Pharmaceuticals Inc, Key Facts

RespireRx Pharmaceuticals Inc, Key Employees

RespireRx Pharmaceuticals Inc, Key Employee Biographies

RespireRx Pharmaceuticals Inc, Major Products and Services

RespireRx Pharmaceuticals Inc, History

RespireRx Pharmaceuticals Inc, Subsidiaries

RespireRx Pharmaceuticals Inc, Key Competitors

RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

RespireRx Pharmaceuticals Inc, Recent Deals Summary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

RespireRx Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Vivus Inc

Mylan Pharmaceuticals Inc

Collegium Pharmaceutical Inc

Celgene Corp

Abraxis BioScience Inc

Company Profile

Company Profile Title

RespireRx Pharmaceuticals Inc (RSPI)-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

RespireRx Pharmaceuticals Inc (RespireRx), formerly Cortex Pharmaceuticals, Inc. involved in the discovery, development and commercialization of innovative products for the treatment of various respiratory disorders (RD) and CNS problems. RespireRx focuses on attention deficit hyperactivity disorder, obstructive sleep apnea (OSA), spinal cord injury and other neurological disorders. Its lead product, Dronabinol, an oral capsule drug product completed Phase II trials for the treatment of OSA. The company's other pipeline products include CX1739 in Chronic CSA, CX717 in spinal cord injury and opioid; CX1942 in drug induced RD. RespireRx is headquartered in Glen Rock, New Jersey, the US.

RespireRx Pharmaceuticals Inc Key Recent Developments

Jan 03,2019: RespireRx Pharmaceuticals names James Sapirstein as executive vice board chairman

Dec 10,2018: Respirerx Pharmaceuticals executives presenting at the international cannabinoid derived pharmaceuticals summit

Jul 25,2018: RespireRx Pharmaceuticals Announces Publication of Ampakine Data

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

RespireRx Pharmaceuticals Inc-Key Facts

RespireRx Pharmaceuticals Inc-Key Employees

RespireRx Pharmaceuticals Inc-Key Employee Biographies

RespireRx Pharmaceuticals Inc-Major Products and Services

RespireRx Pharmaceuticals Inc-History

RespireRx Pharmaceuticals Inc-Company Statement

RespireRx Pharmaceuticals Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

RespireRx Pharmaceuticals Inc-Business Description

RespireRx Pharmaceuticals Inc-SWOT Analysis

SWOT Analysis-Overview

RespireRx Pharmaceuticals Inc-Strengths

RespireRx Pharmaceuticals Inc-Weaknesses

RespireRx Pharmaceuticals Inc-Opportunities

RespireRx Pharmaceuticals Inc-Threats

RespireRx Pharmaceuticals Inc-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

RespireRx Pharmaceuticals Inc, Recent Deals Summary

Section 4-Company's Recent Developments

Jan 03, 2019: RespireRx Pharmaceuticals names James Sapirstein as executive vice board chairman

Dec 10, 2018: Respirerx Pharmaceuticals executives presenting at the international cannabinoid derived pharmaceuticals summit

Jul 25, 2018: RespireRx Pharmaceuticals Announces Publication of Ampakine Data

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

RespireRx Pharmaceuticals Inc, Key Facts

RespireRx Pharmaceuticals Inc, Key Employees

RespireRx Pharmaceuticals Inc, Key Employee Biographies

RespireRx Pharmaceuticals Inc, Major Products and Services

RespireRx Pharmaceuticals Inc, History

RespireRx Pharmaceuticals Inc, Subsidiaries

RespireRx Pharmaceuticals Inc, Key Competitors

RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

RespireRx Pharmaceuticals Inc, Recent Deals Summary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

RespireRx Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Vivus Inc

Mylan Pharmaceuticals Inc

Collegium Pharmaceutical Inc

Celgene Corp

Abraxis BioScience Inc